Ari Raved is Director at AIT Therapeutics, Inc. (AITB). They have made 1 open-market trade across 1 company since 2018, most recently 2018-06-22.
CIK 0001704289
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2018, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AITB | 565,885 | $3.0M |
Shares reported on the most recent Form 4, priced at the 2018-06-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AITB | SELL | 2018-06-22 | 2018-06-27 | $3.20 | $237K | +2.5% | +10.5% | +10.5% |